AESGP Hearing at HMPC Meeting Report – May 2022 AESGP Hearing at HMPC Meeting Report – May 2022 EMA has published the report of the AESGP hearing at the... AESGP Hearing at HMPC Meeting Report – May 2022
HMA 109th Meeting Highlights – September 2022 HMA 109th Meeting Highlights – September 2022 The Heads of Medicines Agencies (HMA) have published the highlights... HMA 109th Meeting Highlights – September 2022
Titanium Dioxide – Global Safety Review Updates Titanium Dioxide – Global Safety Review Updates AESGP has provided a summary of new developments related to titanium dioxide globablly,... Titanium Dioxide – Global Safety Review Updates
HPRA – Guidance Update HPRA – Guidance Update The Health Products Regulatory Authority (HPRA) has updated its Guide to Batch-Specific Requests... HPRA – Guidance Update
Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs The European Medicines Agency (EMA) and the... Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs
PAGB OTC Medicines Pack Design Workshop PAGB OTC Medicines Pack Design Workshop The PAGB ‘OTC Medicines Pack Design Workshop’ will take place online on Wednesday 2... PAGB OTC Medicines Pack Design Workshop
EMA HMPC Meeting Report – September 2022 EMA’s Committee on Herbal Medicinal Products (HMPC) has published the report from their September 2022 meeting EMA’s Committee on Herbal... EMA HMPC Meeting Report – September 2022
Digital Application Dataset Integration (DADI) Network Project Q&A and Timeline Updated Digital Application Dataset Integration (DADI) Network Project Q&A and Timeline Updated The European Medicines Agency (EMA) has published the updated... Digital Application Dataset Integration (DADI) Network Project Q&A and Timeline Updated
MHRA Publishes Marketing Authorisations Granted in September 2022 MHRA’s list of marketing authorisations granted in September 2022 MHRA granted four licences in September 2022. Details of the marketing... MHRA Publishes Marketing Authorisations Granted in September 2022
European Commission Decision Reliance Procedure (EC DRP) Extension European Commission Decision Reliance Procedure (EC DRP) Extension The European Commission Decision Reliance Procedure (EC DRP) has been extended by... European Commission Decision Reliance Procedure (EC DRP) Extension
EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making The European Medicines Agency (EMA) has... EMA Workshop on Patient Experience Data in Medicines Development and Regulatory Decision-making
EMA PRAC Meeting Highlights – September 2022 EMA PRAC Meeting Highlights – September 2022 The European Medicines Agency (EMA) has published the meeting highlights from... EMA PRAC Meeting Highlights – September 2022
